| Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients S Blitshteyn, S Whitelaw Immunologic research 69 (2), 205-211, 2021 | 273 | 2021 |
| Is there an association between meningioma and hormone replacement therapy? S Blitshteyn, JE Crook, KA Jaeckle Journal of Clinical Oncology 26 (2), 279-282, 2008 | 161 | 2008 |
| P ostural tachycardia syndrome following human papillomavirus vaccination S Blitshteyn European Journal of Neurology 21 (1), 135-139, 2014 | 123 | 2014 |
| Autoimmune markers and autoimmune disorders in patients with postural tachycardia syndrome (POTS) S Blitshteyn Lupus 24 (13), 1364-1369, 2015 | 113 | 2015 |
| Postural tachycardia syndrome after vaccination with Gardasil S Blitshteyn European Journal Of Neurology: 17 (7), e52, 2010 | 57 | 2010 |
| Postural tachycardia syndrome (POTS) with anti-NMDA receptor antibodies after human papillomavirus vaccination S Blitshteyn, J Brook Immunologic research 65, 282-284, 2017 | 55 | 2017 |
| Multi‐disciplinary collaborative consensus guidance statement on the assessment and treatment of autonomic dysfunction in patients with post‐acute sequelae of SARS‐CoV‐2 … S Blitshteyn, JH Whiteson, B Abramoff, A Azola, MN Bartels, ... PM&R 14 (10), 1270-1291, 2022 | 51 | 2022 |
| Autonomic dysfunction and HPV immunization: an overview S Blitshteyn, L Brinth, JE Hendrickson, M Martinez-Lavin Immunologic Research 66 (6), 744-754, 2018 | 50 | 2018 |
| Postural tachycardia syndrome (POTS) and other autonomic disorders in antiphospholipid (Hughes) syndrome (APS) JR Schofield, S Blitshteyn, Y Shoenfeld, GRV Hughes Lupus 23 (7), 697-702, 2014 | 35 | 2014 |
| Is postural orthostatic tachycardia syndrome (POTS) a central nervous system disorder? S Blitshteyn Journal of Neurology 269 (2), 725-732, 2022 | 33 | 2022 |
| Nonconvulsive status epilepticus in metastatic CNS disease S Blitshteyn, KA Jaeckle Neurology 66 (8), 1261-1263, 2006 | 32 | 2006 |
| Vitamin B1 deficiency in patients with postural tachycardia syndrome (POTS) S Blitshteyn Neurological research 39 (8), 685-688, 2017 | 30 | 2017 |
| Multi‐disciplinary collaborative consensus guidance statement on the assessment and treatment of cardiovascular complications in patients with post‐acute sequelae of SARS‐CoV‐2 … JH Whiteson, A Azola, JT Barry, MN Bartels, S Blitshteyn, TK Fleming, ... Pm & R 14 (7), 855, 2022 | 29 | 2022 |
| Chronic fatigue syndrome: from chronic fatigue to more specific syndromes S Blitshteyn, P Chopra European Neurology 80 (1-2), 73-77, 2018 | 26 | 2018 |
| Pregnancy in postural tachycardia syndrome: clinical course and maternal and fetal outcomes S Blitshteyn, H Poya, GCL Bett The Journal of Maternal-Fetal & Neonatal Medicine 25 (9), 1631-1634, 2012 | 24 | 2012 |
| Pure sensory stroke as an isolated manifestation of the lateral medullary infarction S Blitshteyn, FA Rubino Journal of Neuroimaging 15 (1), 82-84, 2005 | 20 | 2005 |
| Prevalence of gastrointestinal, cardiovascular, autonomic and allergic manifestations in hospitalized patients with Ehlers-Danlos syndrome: a case-control study RS Brooks, J Grady, TW Lowder, S Blitshteyn Rheumatology 60 (9), 4272-4280, 2021 | 18 | 2021 |
| Transient vertical diplopia and nystagmus associated with acute thalamic infarction S Blitshteyn, K Hentschel, LF Czervionke, BH Eidelman Clinical imaging 30 (1), 54-56, 2006 | 15 | 2006 |
| The risks of POTS after COVID-19 vaccination and SARS-CoV-2 infection: More studies are needed S Blitshteyn, A Fedorowski Nature Cardiovascular Research 1 (12), 1119-1120, 2022 | 14 | 2022 |
| Dysautonomia, hypermobility spectrum disorders and mast cell activation syndrome as migraine comorbidities S Blitshteyn Current Neurology and Neuroscience Reports 23 (11), 769-776, 2023 | 12 | 2023 |
